Rydex Biotechnology Inv (RYOIX)
Stock analysis · NASDAQ · Financial Services · Asset Management
Rydex Biotechnology Inv (RYOIX) is a publicly traded company in the Financial Services sector. Latest price: $98.81. Market cap $104.26M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Rydex Biotechnology Inv
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap